Ovation Science (OVATF) Price & Analysis

Compare

3 Followers

OVATF Stock Chart & Stats

$0.03

-$0.01(-48.03%)

At close: Jan 08 4:00 PM EST

$0.03

-$0.01(-48.03%)

Day’s Range― - ―

52-Week Range$0.01 - $0.05

Previous CloseN/A

Volume16.00K

Average Volume (3M)614.00

Market Cap

$775.04K

Enterprise Value$1.23M

Total Cash (Recent Filing)$5.55K

Total Debt (Recent Filing)$275.51K

Price to Earnings (P/E)―

Beta-0.53

Next Earnings

Apr 30, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding35,244,682

10 Day Avg. Volume233

30 Day Avg. Volume614

Financial Highlights & Ratios

PEG Ratio0.05

Price to Book (P/B)-1.12

Price to Sales (P/S)10.81

P/FCF Ratio-6.85

Enterprise Value/Market Cap1.59

Enterprise Value/Revenue19.02

Enterprise Value/Gross Profit21.11

Enterprise Value/Ebitda-3.06

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Proprietary Topical Delivery PlatformOvation’s IntelliGel platform is a durable competitive asset: a technology backbone that can be applied across therapeutic and consumer skin-health products. A reproducible delivery platform supports licensing, partnerships, and product diversification, improving long-term revenue optionality and higher-margin opportunities.

2024 Performance Improved Vs 2023The company narrowed losses and grew revenue in 2024 versus 2023, signaling progress toward operational stabilization. If sustained, this trend lengthens runway, reduces urgency for dilutive financing, and indicates management can incrementally scale revenues while trimming loss drivers over a multi-quarter horizon.

Reduced Cash Burn In 2024An improving cash-burn trajectory is a meaningful structural sign when persistent: reduced outflows in 2024 demonstrate cost control or revenue leverage beginning to take hold. Continued improvement would materially extend liquidity runway and lower solvency risk absent immediate external funding.

Bears Say

Persistent Operating And Net LossesSustained operating and net losses plus recurring negative cash flow materially constrain strategic flexibility. Over multiple quarters this forces reliance on external financing, increases dilution risk, limits R&D or commercial investment, and undermines the company’s ability to achieve self-sustaining growth absent a structural business change.

Negative Shareholders' Equity And Rising DebtNegative equity and growing debt indicate balance-sheet stress that reduces borrowing capacity and creditor confidence. This structural weakness elevates insolvency risk, constrains capital allocation, and makes the company more vulnerable to adverse shocks or costly refinancing, limiting long-term resilience.

Deeply Negative Margins And Volatile RevenueVolatile, materially reduced revenue and roughly -400% net margins reflect a business that cannot yet scale profitably. Such structural margin deficits mean even modest revenue growth won't translate to earnings without significant cost or model change, threatening sustainable cash generation and long-term viability.

Ovation Science News

Ovation Science Wins Canadian Patent, Bolstering IP and Licensing Prospects for Topical Cannabis Line

Ovation Science ( ($TSE:OVAT) ) just unveiled an announcement. Ovation Science has secured a new Canadian patent for...

1M ago

Ovation Science Grants 2.2 Million Stock Options to Directors and Officers

An announcement from Ovation Science ( ($TSE:OVAT) ) is now available. Ovation Science Inc. has granted 2.2 million...

1M ago

Ovation Science Inc. Launches $200,000 Private Placement to Boost Operations

The latest update is out from Ovation Science ( ($TSE:OVAT) ). Ovation Science Inc. announced a non-brokered private...

5M ago

Ovation Science Expands Cannabis Topicals into Florida with Planet 13 Partnership

The latest announcement is out from Ovation Science ( ($TSE:OVAT) ). Ovation Science Inc. has expanded its license...

7M ago

Ovation Science Launches Cannabis Topicals in Nevada

Ovation Science (TSE:OVAT) has released an update. Ovation Science Inc. has partnered with Planet 13 Holdings, Inc. to...

2y ago

Ovation Science Inc. Plans Capital Boost

Ovation Science (TSE:OVAT) has released an update. Ovation Science Inc. has announced a private placement aiming to raise...

2y ago

OVATF FAQ

What was Ovation Science Inc’s price range in the past 12 months?

Ovation Science Inc lowest stock price was $0.01 and its highest was $0.05 in the past 12 months.

What is Ovation Science Inc’s market cap?

Ovation Science Inc’s market cap is $775.04K.

When is Ovation Science Inc’s upcoming earnings report date?

Ovation Science Inc’s upcoming earnings report date is Apr 30, 2026 which is in 71 days.

How were Ovation Science Inc’s earnings last quarter?

Ovation Science Inc released its earnings results on Nov 20, 2025. The company reported -$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.003.

Is Ovation Science Inc overvalued?

According to Wall Street analysts Ovation Science Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Ovation Science Inc pay dividends?

Ovation Science Inc does not currently pay dividends.

What is Ovation Science Inc’s EPS estimate?

Ovation Science Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Ovation Science Inc have?

Ovation Science Inc has 35,244,682 shares outstanding.

What happened to Ovation Science Inc’s price movement after its last earnings report?

Ovation Science Inc reported an EPS of -$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Ovation Science Inc?

Currently, no hedge funds are holding shares in OVATF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Ovation Science Inc

Ovation Science Inc. engages in the production of cannabis or hemp products in Canada, the United States, and Mexico. The company's Invisicare is a patented drug delivery technology for use in topical and transdermal skin care products containing hemp seed oil and cannabis under the Ovation and BASKiN brands. It offers cannabidiol infused health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and hand sanitizers under the DermSafe name. The company holds sublicenses for cannabis based products; and Lighthouse for licensed dispensaries in the United States. Ovation Science Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.